Biotics Research Corporation/LinkedIn
Nov 25, 2025, 12:32
Immune Profile and Nausea Link in Early Pregnancy – Biotics Research Corporation
Biotics Research Corporation shared a post on LinkedIn:
“New research sheds light on how the immune system may drive common first-trimester symptoms – like nausea, vomiting, and food or odor aversions. A study of 58 pregnant women found that a more inflammatory immune profile was linked to stronger and longer-lasting aversions and nausea
Key findings:
- 64% reported odor aversions (especially to tobacco smoke)
- 64% reported food aversions, most often to meat
- Higher Th1 inflammatory immune activity was associated with more nausea, vomiting, and aversions
- Suggests these symptoms may be part of an adaptive, protective immune response during early pregnancy”
Read the full article.
Stay updated on all scientific advances in the field of fertility with Fertility News.
Adaptive Immune Response
Biotics Research Corporation
Fertility
Fertility News
First-Trimester Symptoms
Food Aversions
Health Insights
Immune Response
immune system
Inflammatory Immune Profile
maternal health
Nausea
Odor Aversions
Pregnancy Research
Pregnancy Symptoms
Th1 Inflammatory Activity
Vomiting
Women’s Health
-
Apr 1, 2026, 13:32Pregnancy Loss Leave and Recognition in Ireland! – PLRG
-
Apr 1, 2026, 13:19Christopher Robinson: Immune Tolerance Breakdown In Pregnancy!
-
Apr 1, 2026, 13:14How Many Cells Are Enough in Blastocyst Biopsy? – Fertility Plus
-
Apr 1, 2026, 13:09Follicular Fluid PFAS May Influence IVF Outcomes – Fertility and Sterility
-
Apr 1, 2026, 12:48Taarika Ramesh: Rethinking IVF Stimulation With Progestin-Primed Protocols
-
Apr 1, 2026, 12:41Shivam Jha: What is the Importance of Ultrasound During Pregnancy?
-
Apr 1, 2026, 12:18Abnormal Spermogram Is Not an Explanation, It Is a Starting Point – Cesar Fertility
-
Apr 1, 2026, 11:41Christopher Robinson: Racial Disparities in Postoperative Benign Hysterectomy Outcomes
-
Apr 1, 2026, 11:26Sergei Gorlovetsky: Most Fertility Clinics Are Losing Patients Between Interested and Started Treatment
